KLK3 and prostate carcinoma: The eight proteins highlighted in this study (KLK3, SORD, SPON2, IMPDH2, ACTN4, ATP1B1, HSPB1, and KHDRBS1) represent a signature associated with AR modulation during the transition from androgen-dependent to castration-resistant prostate cancers.